It has been reported that, hyperglycaemia is more common in patients with coronavirus disease 2019 (COVID-19). COVID-19, which triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), can cause extrapulmonary symptoms such as diabetes mellitus (DM) and hyperglycaemia, which both indicate a poor prognosis and a higher chance of death.SARS-CoV-2 infects the pancreas through angiotensin-converting enzyme 2 (ACE2), which is abundantly expressed in the pancreas relative to other organs, causing pancreatic damage, insulin secretion impairment, and hyperglycemia in non-DM patients. Thus, the present study provides an overview of the potential association or relation or linkage between COVID-19 and hyperglycemia as a risk factor for the development of diabetes mellitus in relation to diabetes pharmacotherapy.
IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.
